Lynx1 Capital Management LP: PASSAGE BIO INC (PASG): Quarterly 13F Position History
As of Q2 2026, Lynx1 Capital Management LP reported 673,759 shares of PASSAGE BIO INC (PASG), worth $3.3M and representing 0.6% of its 13F equity book. Quarter-over-quarter share count change: + 50,055 (+8.0%) . The position first appeared in Q3 2025 and has been disclosed across 4 13F-HR filings in Pactolio's tracked window.
- 673,759Shares Held (Latest Filing)
- $3.3MReported Market Value (Latest Filing)
- 0.6%Portfolio Weight (% of 13F Equity Book)
- +50,055Quarter-over-Quarter Share Change
- -$1.6MQuarter-over-Quarter Value Change
- 673,759Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 4 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 673,759 | +50,055 | +8.0% | $3.3M | 0.6% | $4.9 |
| Q1 2026 | 623,704 | 0 | – | $4.9M | 0.8% | $7.8 |
| Q4 2025 | 623,704 | 0 | – | $7.4M | 1.5% | $11.8 |
| Q3 2025 | 623,704 | – | – | $5.0M | 1.0% | $8.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Lynx1 Capital Management LP first disclose a PASG position in 13F-HR filings?
Lynx1 Capital Management LP first reported PASSAGE BIO INC (PASG) on its 13F-HR filing for the period ending 2025-09-30 (Q3 2025). The position has appeared on 4 reported quarters within Pactolio's tracked window.
What was Lynx1 Capital Management LP's most recent quarter-over-quarter share-count change in PASG?
Between Q1 2026 and Q2 2026, Lynx1 Capital Management LP added 50,055 shares of PASG (+8.0%), bringing the total reported position to 673,759 shares at a market value of $3.3M.
Does the implied price-per-share represent Lynx1 Capital Management LP's cost basis in PASG?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.